173 related articles for article (PubMed ID: 35734827)
1. Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein.
Luangwattananun P; Chiraphapphaiboon W; Thuwajit C; Junking M; Yenchitsomanus PT
Bioengineered; 2022 Jun; 13(6):14188-14203. PubMed ID: 35734827
[TBL] [Abstract][Full Text] [Related]
2. Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy.
Luangwattananun P; Junking M; Sujjitjoon J; Wutti-In Y; Poungvarin N; Thuwajit C; Yenchitsomanus PT
Breast Cancer Res Treat; 2021 Feb; 186(1):25-36. PubMed ID: 33389403
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.
Sundarasetty BS; Singh VK; Salguero G; Geffers R; Rickmann M; Macke L; Borchers S; Figueiredo C; Schambach A; Gullberg U; Provasi E; Bonini C; Ganser A; Woelfel T; Stripecke R
Hum Gene Ther; 2013 Feb; 24(2):220-37. PubMed ID: 23311414
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.
Sundarasetty BS; Chan L; Darling D; Giunti G; Farzaneh F; Schenck F; Naundorf S; Kuehlcke K; Ruggiero E; Schmidt M; von Kalle C; Rothe M; Hoon DS; Gerasch L; Figueiredo C; Koehl U; Blasczyk R; Gutzmer R; Stripecke R
Gene Ther; 2015 Sep; 22(9):707-20. PubMed ID: 25965393
[TBL] [Abstract][Full Text] [Related]
5. Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level.
Song DG; Ye Q; Poussin M; Chacon JA; Figini M; Powell DJ
J Hematol Oncol; 2016 Jul; 9(1):56. PubMed ID: 27439908
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
Panya A; Thepmalee C; Sawasdee N; Sujjitjoon J; Phanthaphol N; Junking M; Wongkham S; Yenchitsomanus PT
Cancer Immunol Immunother; 2018 Oct; 67(10):1579-1588. PubMed ID: 30056600
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T Cells Activated by Self-differentiated Monocyte-derived Dendritic Cells Against Multiple Myeloma Cells.
Chiraphapphaiboon W; Luangwattananun P; Panya A; Jirapongwattana N; Punnakitikashem P; Chieochansin T; Junking M; Yenchitsomanus PT
Anticancer Res; 2022 Apr; 42(4):1785-1799. PubMed ID: 35346997
[TBL] [Abstract][Full Text] [Related]
8. A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Avanzino BC; Prabhakar K; Dalvi P; Hartstein S; Kehm H; Balasubramani A; Boudreau AA; Buelow B; Chang K; Davison LM; Iyer S; Kalwit V; Lewis Wilson K; Malik-Chaudhry HK; Pierson W; Pineda G; Rangaswamy US; Saiganesh S; Schellenberger U; Ugamraj HS; Yabut RD; Buelow R; Chapman J; Trinklein ND; Harris KE
Oncoimmunology; 2022; 11(1):2113697. PubMed ID: 36016696
[TBL] [Abstract][Full Text] [Related]
9. Production of a High-affinity Monoclonal Antibody Reactive with Folate Receptors Alpha and Beta.
Nagai T; Furusho Y; Li H; Hasui K; Matsukita S; Sueyoshi K; Yanagi M; Hatae M; Takao S; Matsuyama T
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):181-90. PubMed ID: 26090596
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.
Neglia F; Orengo AM; Cilli M; Meazza R; Tomassetti A; Canevari S; Melani C; Colombo MP; Ferrini S
Cancer Gene Ther; 1999; 6(4):349-57. PubMed ID: 10419053
[TBL] [Abstract][Full Text] [Related]
12. Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.
Pincha M; Sundarasetty BS; Salguero G; Gutzmer R; Garritsen H; Macke L; Schneider A; Lenz D; Figueiredo C; Blasczyk R; Ruggiero E; Schmidt M; von Kalle C; Puff C; Modlich U; von der Leyen H; Wicke DC; Ganser A; Stripecke R
Hum Gene Ther Methods; 2012 Feb; 23(1):38-55. PubMed ID: 22428979
[TBL] [Abstract][Full Text] [Related]
13. CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor α based DNA vaccine.
Qiu Z; Xing L; Zhang X; Qiang X; Xu Y; Zhang M; Zhou Z; Zhang J; Zhang F; Wang M
Oncol Rep; 2017 Jun; 37(6):3441-3448. PubMed ID: 28498413
[TBL] [Abstract][Full Text] [Related]
14. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
15. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
16. [Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].
Wang XL; Ma B; Jia J; Yuan YH; Yan Y; Di LJ; Song GH; Yu J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):173-8. PubMed ID: 21503107
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L
AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
[TBL] [Abstract][Full Text] [Related]
20. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
DeCarlo A; Malardier-Jugroot C; Szewczuk MR
Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]